Highline Wealth Partners’s Xylem XYL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.01K Buy
10
+4
+67% +$458 ﹤0.01% 1339
2026
Q2
$709 Buy
6
+3
+100% +$346 ﹤0.01% 1311
2026
Q1
$359 Hold
3
– – ﹤0.01% 1260
2025
Q4
$409 Hold
3
– – ﹤0.01% 1002
2025
Q3
$443 Hold
3
– – ﹤0.01% 1007
2025
Q2
$388 Sell
3
-5
-63% -$606 ﹤0.01% 817
2025
Q1
$956 Hold
8
– – ﹤0.01% 753
2024
Q4
$928 Buy
+8
New +$1.01K ﹤0.01% 538
2024
Q3
– Sell
-3
Closed -$407 – 646
2024
Q2
$407 Buy
+3
New +$408 ﹤0.01% 503

Other funds holding XYL

Highline Wealth Partners's XYL Position: Q3 2026 in Review

Highline Wealth Partners increased its Xylem (XYL) stake by 67% in Q3 2026, buying an estimated $458 and bringing the position to 10 shares worth $1.01K. The position accounts for ﹤0.01% of the portfolio, ranked #1339.

Highline Wealth Partners first reported a position in XYL in Q2 2024 and has held it in 9 quarters since. 656 funds tracked by Wall St. Rank hold XYL as of Q3 2026.

  • Highline Wealth Partners held 10 shares of Xylem worth $1.01K as of Q3 2026.
  • Highline Wealth Partners bought 4 Xylem shares in Q3 2026, an estimated $458.
  • Xylem made up ﹤0.01% of Highline Wealth Partners's portfolio in Q3 2026, its #1339 holding.
  • Highline Wealth Partners first reported a position in Xylem in Q2 2024 and has held it in 9 quarters since.
  • 656 funds tracked by Wall St. Rank held Xylem as of Q3 2026.

Based on Highline Wealth Partners's 13F filing for Q3 2026, filed 19 Oct 2026.